Career

Current Appointment

  • Michigan State University
  • Clinical Associate Professor, Department of Pediatrics and Human Development

Past Appointments

  • Hurley Medical Center
  • Chief of Pediatric Gastroenterology, Department of Pediatrics

Board Certification

1997 – Present

  • American Board of Pediatrics
  • Subspecialty: Gastroenterology #000537

Membership in Professional Societies

  • 7/94 – Present North American Society for Pediatric Gastroenterology & Nutrition
  • 8/04 – Present Michigan State Medical Society (MSMS)
  • 4/08 – Present American Society for Gastrointestinal Endoscopy

Committees

10/09 – Present

  • Board of Directors Genesee County Medical Society

Clinical Research Experience

2006 Principal Investigator

  • A Phase 3, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group Study Assessing the Safety and Efficacy of XXX Microgranules Oral Suspension in Infants with Symptomatic Gastroesophageal Reflux Disease

2007 Principal Investigator

  • A Multicenter, Randomized, Double-Blind Study of the Clinical Outcomes, Safety and Tolerability of Multiple Doses of XXX in Children Ages 1 To 5, With Endoscopically Proven Symptomatic GERD

2007 Principal Investigator

  • A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Treatment-Withdrawal Study of the Efficacy and Safety of XXX in Infants (1 Through 11 Months) With Symptomatic GERD

2007 Principal Investigator

  • A Multicenter, Randomized, Open Label, Single, and Multiple Dose Study of the Safety and Pharmacokinetics of 2 Dose Levels of XXX in Children Aged 1 Through 11 Years with Endoscopically Proven GERD

2007 Sub- Investigator

  • A Multicenter, Open-Label Pharmacokinetic, Pharmacodynamic, Clinical Symptoms, and Safety Study of XXX Administered as a Suspension in Neonates and Preterm Infants with a Clinical Diagnosis of Gastroesophageal Reflux Disease

2008 Principal Investigator

  • A Multicenter, Open-Label, Ascending, Multiple-Dose Study to Assess the Pharmacokinetics, Safety, and Tolerability of XXX in Patients 8-11 Years of Age with Selected Serious Infections

2009 Principal Investigator

  • A Multi-Center, Double-Blind, Parallel-Group Study to Evaluate Short-Term Safety and Efficacy and Long-term Maintenance of Two Dose Levels of XXX in 1- to 11-Year-Old Pediatric Subjects with Endoscopically Proven GERD

2010 Principal Investigator

  • A Multi-Center, Double-Blind, Parallel-Group Study to Evaluate Short-Term Safety and Efficacy and Long-term Maintenance of Two Dose Levels of XXX in 0-1 Year-Old Pediatric Subjects with GERD

Honors and Awards

April 2009

  • Faculty Investigator Award MSU, Hurley Medical Center, Flint, MI